A potential disease-modifying treatment for osteoarthritis from Cynata Therapeutics

/in ,

A potential disease-modifying treatment for osteoarthritis from Cynata Therapeutics Osteoarthritis is a chronic inflammatory joint disease that causes pain and disability, affecting over two million people in Australia and over 500 million people worldwide. Currently, there are no approved disease-modifying therapies for osteoarthritis, with treatment options limited to symptom management. Cynata is developing CYP-004, our Cymerus™ off-the-shelf iPSC-derived […]

Read more

Humanetix joins forces with Provider Assist to drive end-to-end people, business, and digital solutions.

/in , ,

Humanetix joins forces with Provider Assist to drive end-to-end people, business, and digital solutions. BioScience Managers is proud to share that portfolio company Humanetix (HX) has entered a strategic acquisition Provider Assist (PA), a leading healthcare solutions provider in Australia. This milestone represents a robust validation of Humanetix’s technology and its impact in aged […]

Read more

Adherium announces interim results from the iCare respiratory care program

/in ,

Adherium announces interim results from the iCare respiratory care program Adherium has today announced interim results from the iCARE respiratory care program, demonstrating positive clinical outcomes, including breakthrough adherence and patient engagement, whilst using Adherium’s Hailie® Smartinhaler technology. The iCARE program, conducted in partnership with Intermountain Health and CareCentra, is one of the largest real-world […]

Read more

Cynata Therapeutics release its Appendix 4E and Annual Report

/in ,

Cynata Therapeutics release its Appendix 4E and Annual Report Cynata Therapeutics has released its Appendix 4E and Annual Report, reflecting a year of strong momentum and significant progress across its clinical pipeline. As Independent Chair, Dr Geoff Brooke states, “Cynata is entering what I believe will be the most pivotal year in our history. Within […]

Read more